28.06.2011 • NewsBain CapitalDow spinoff Styronpolystyrene

Trinseo Files For IPO Of Up To $400 Million

Plastics maker Trinseo, better known as Styron, filed with U.S. regulators on Monday to raise up to $400 million in an initial public offering, making it the latest private equity-backed company to tap the public markets.

Trinseo joins a growing list of private equity-backed listings such as consumer research firm Nielsen Holdings , Florida lender BankUnited Inc, pipeline company Kinder Morgan Inc and hospital operator HCA Holdings Inc and others.

Bain Capital bought Styron for $1.63 billion from Dow Chemical in 2010.

The IPO would be an unusually quick exit for Bain, as buyout firms such as the company tend to hold investments for a few years.
Dow Chemical still has a 7.5% stake in the company.

In March, Reuters reported that the company was planning an IPO and was in the process of picking banks to lead the offering.

The company has 11 banks underwriting its IPO, which is being spearheaded by investment banking heavyweights such as Goldman Sachs, Citi, Deutsche Bank Securities and Barclays Capital.

Berwyn, Pa.-centered Trinseo intends to use some of the net proceeds from the offering to repay its $1.4 billion term loan.

The holding company, which generated $5 billion in 2010 net sales and raked in a profit of $41.1 million, operates in Europe, Middle East, Asia Pacific, North America, and Latin America.

The company plans to list its ordinary shares under the symbol TSE.

The amount of money a company says it plans to raise in its first IPO filings is used to calculate registration fees. The final size of the IPO can be different.

 

 

Company

Styron

2030 Dow Center
48674-0001 Midland

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.